Study title:
Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Bacterial Infections and Mycoses [C01]
|
Brands: |
MAH holders: Please see report |
Assessment: |
Active substance: TEICOPLANIN |
ATC code: J01XA02 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|